Sionna Therapeutics
高管
查看带有其 21 名主要高管的组织结构图
Sionna Therapeutics 搜索最多的简介
- Mike Cloonan, Director, President and Chief Executive Officer
- Laurie Stelzer, Director
- Edd Fleming, Director
高管在Sionna Therapeutics变化
- Laurie Stelzer已作为Director加入公司 (新闻发布的2024十一月19号).
- Jennifer Fitzpatrick已作为Senior Vice President and General Counsel加入公司 (新闻发布的2024六月4号).
创建提醒
跟踪 Sionna Therapeutics 的高管变动
生物技术
Sionna Therapeutics 拥有 2,337 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Aadi Bioscience 刚刚宣布为 100 筹款数百万美元。 (公布2024十二月20号).
- OraSure Technologies has announced the acquisition of Sherlock Biosciences (公布2024十二月20号).
- SiteOne Therapeutics 刚刚宣布为 100 筹款数百万美元。 (公布2024十二月20号).
生物技术 行业的其他推荐联系人
消息
Sionna Therapeutics 的最新新闻稿
- Sionna Therapeutics Expands Pipeline with Multiple Clinical Stage Cystic Fibrosis Compounds Through a License Agreement with AbbVie - Sionna Therapeutics
- Sionna Therapeutics Announces Initiation of Two Phase 1 Clinical Trials of SION-719 and SION-451, in Development for Cystic Fibrosis - Sionna Therapeutics
- Sionna Therapeutics Announces Appointment of Jennifer Fitzpatrick as General Counsel - Sionna Therapeutics
- Sionna Therapeutics Announces $182 Million Series C Financing to Advance Clinical Development of Novel Small Molecules in Cystic Fibrosis - Sionna Therapeutics
- Sionna Therapeutics Announces Phase 1 Initiation for SION-109 in Cystic Fibrosis – Sionna Therapeutics
- Sionna Therapeutics to Present Updates on Clinical Progress in Cystic Fibrosis at 42nd Annual J.P. Morgan Healthcare Conference – Sionna Therapeutics
- Sionna Therapeutics Presents Preclinical Data at 2023 North American Cystic Fibrosis Conference Demonstrating Series 2 NBD1 Stabilizers Normalize ΔF508-CFTR Function – Sionna Therapeutics
- Sionna Therapeutics to Present at 2023 North American Cystic Fibrosis Conference – Sionna Therapeutics
- Sionna Therapeutics Announces Presentation of Preclinical Data on NBD1 Stabilizers at 46th European Cystic Fibrosis Conference – Sionna Therapeutics
- Sionna Therapeutics Announces Advancement of Cystic Fibrosis Pipeline Programs and Presentation at J.P. Morgan 41st Annual Healthcare Conference – Sionna Therapeutics
- View more press releases Close
通过电子邮件
